Related Experiment Videos
A chimeric EGFR/neu receptor in functional analysis of the neu oncoprotein
L Lehtola1, H Lehväslaiho, P Koskinen
1Department of Virology, University of Helsinki, Finland.
Abstract:
As the factor binding to the neu protein has been unknown, it has not been possible to confirm experimentally the proposed growth-factor receptor like functions of the neu protein. To approach this problem we constructed a recombinant receptor which enabled ligand regulation of the neu tyrosine kinase. The hybrid receptor consisted of the extracellular ligand binding, transmembrane and protein kinase C-substrate domains joined to the intracellular tyrosine kinase and carboxyl-terminal domains of the neu protein. Several properties of NIH3T3 cells carrying this construct were tested. We obtained the first experimental evidence that the neu proto-oncogene has mitogenic and transforming activities only in the presence of a ligand stimulating its tyrosine kinase activity. Various cellular and molecular biological parameters indicated that the chimeric receptor behaved very similarly to the EGFR. Also, this chimeric receptor has allowed us to compare the constitutive oncogenic and the ligand-activated non-oncogenic activities of the neu tyrosine kinase. In the future we plan to focus on characterization of possible differences between EGFR and neu signalling in more differentiated cellular backgrounds.
Insights
Researchers found the neu protein requires a ligand to activate its growth factor receptor functions, demonstrating its role in cell growth and transformation. This discovery provides the first experimental evidence for neu's activity, paving the way for further research.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The ligand-binding capabilities and growth factor receptor functions of the neu protein were previously unconfirmed experimentally.
- Understanding neu protein's interactions is crucial for elucidating its role in cell signaling and disease.
Purpose of the Study:
- To experimentally validate the proposed growth-factor receptor-like functions of the neu protein.
- To investigate the ligand-dependent activation of neu tyrosine kinase activity.
- To compare neu signaling with Epidermal Growth Factor Receptor (EGFR) pathways.
Main Methods:
- Construction of a recombinant hybrid receptor combining extracellular domains with intracellular neu protein domains.
- Expression of the chimeric receptor in NIH3T3 cells.
- Assessment of cellular and molecular biological parameters, including mitogenic and transforming activities.
Main Results:
- The study provides the first experimental evidence that the neu proto-oncogene exhibits mitogenic and transforming activities only when stimulated by a ligand.
- The chimeric receptor demonstrated functional similarities to EGFR.
- The research enabled a comparison between constitutive oncogenic and ligand-activated non-oncogenic activities of neu tyrosine kinase.
Conclusions:
- Ligand-dependent activation is essential for the neu protein's mitogenic and transforming functions.
- The neu protein shares functional characteristics with EGFR, suggesting conserved signaling mechanisms.
- Future research will focus on comparing neu and EGFR signaling in differentiated cellular contexts.